Inflammation and immune dysfunction in Parkinson disease

MG Tansey, RL Wallings, MC Houser… - Nature Reviews …, 2022 - nature.com
Parkinson disease (PD) is a progressive neurodegenerative disease that affects peripheral
organs as well as the central nervous system and involves a fundamental role of …

LRRK2 regulation of immune-pathways and inflammatory disease

RL Wallings, MG Tansey - Biochemical Society Transactions, 2019 - portlandpress.com
Mutations in the leucine-rich-repeat kinase 2 (LRRK2) gene are associated with familial and
sporadic cases of Parkinson's disease but are also found in immune-related disorders such …

Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress

MA Eldeeb, AN Bayne, A Fallahi, T Goiran… - Proceedings of the …, 2024 - pnas.org
Mutations in PTEN-induced putative kinase 1 (PINK1) cause autosomal recessive early-
onset Parkinson's disease (PD). PINK1 is a Ser/Thr kinase that regulates mitochondrial …

[HTML][HTML] Structural mechanisms of mitochondrial quality control mediated by PINK1 and parkin

JF Trempe, K Gehring - Journal of Molecular Biology, 2023 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disease and
represents a looming public health crisis as the global population ages. While the etiology of …

[HTML][HTML] Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease

M Taylor, DR Alessi - Current Opinion in Cell Biology, 2020 - Elsevier
Autosomal dominant missense mutations that hyperactivate the leucine-rich repeat protein
kinase-2 (LRRK2) are a common cause of inherited Parkinson's disease and therapeutic …

Advances in the immunology and genetics of leprosy

Z Mi, H Liu, F Zhang - Frontiers in immunology, 2020 - frontiersin.org
Leprosy, a disease caused by the intracellular parasite Mycobacterium leprae or
Mycobacterium lepromatosis, has affected humans for more than 4,000 years and is a …

Small-molecule LRRK2 inhibitors for PD therapy: current achievements and future perspectives

J Hu, D Zhang, K Tian, C Ren, H Li, C Lin… - European Journal of …, 2023 - Elsevier
Leucine-rich repeat kinase 2 (LRRK2) is a multifunctional protein that orchestrates a diverse
array of cellular processes, including vesicle transport, autophagy, lysosome degradation …

The cell biology of LRRK2 in Parkinson's disease

A Usmani, F Shavarebi, A Hiniker - Molecular and cellular biology, 2021 - Taylor & Francis
Point mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of
familial Parkinson's disease (PD) and are implicated in a significant proportion of apparently …

[HTML][HTML] LRRK2 targeting strategies as potential treatment of Parkinson's disease

DN Wojewska, A Kortholt - Biomolecules, 2021 - mdpi.com
Parkinson's Disease (PD) affects millions of people worldwide with no cure to halt the
progress of the disease. Leucine-rich repeat kinase 2 (LRRK2) is the most common genetic …

LRRK2 at the interface between peripheral and central immune function in Parkinson's

RL Wallings, MK Herrick, MG Tansey - Frontiers in Neuroscience, 2020 - frontiersin.org
It is becoming increasingly accepted that there is an interplay between the peripheral
immune response and neuroinflammation in the pathophysiology of Parkinson's disease …